Clinical Studies
-
Ethos Precision Medicine Umbrella Study for Hemangiosarcoma (Ethos-PUSH)
OpenIs your dog undergoing surgery for a ruptured splenic tumor? Ethos Discovery would love to have you and your dog participate in our clinical trial! We are evaluating drugs for the treatment of HSA with the goal of curing this aggressive cancer.
Study Details -
Embolization of the Splenic Artery for Thrombocytopenia (eSPAT)
ClosedImmune-mediated thrombocytopenia (ITP) is a disorder characterized by severely low platelets due to attack by white blood cells. This is often associated with bruising and occasionally severe bleeding episodes.
Study Details -
Evaluating Benefit of a Novel Intra-articular Device in Dogs With a Suspected Cruciate Ligament Tear
ClosedA new veterinary device composed of collagen and elastin particles has been developed; it is delivered via intra-articular injection and helps protect cartilage from mechanical grinding. This study seeks to validate this device as a pre-surgical management tool for dogs with cruciate disease.
Study Details -
Evaluating the Tolerability of a Novel PCNA Inhibitor in Dogs with Cancer
ClosedProliferating cell nuclear antigen (PCNA) is an important protein necessary for the repair of DNA in cells. Cancer cells express a unique type of PCNA (termed caPCNA) which is only found at small quantities in non-cancer cells.
Study Details -
Evaluating the Tolerability of Combination of Verdinexor and Doxorubicin in Dogs with Cancer
ClosedVerdinexor is a chemotherapy drug that has been conditionally approved by the FDA for the treatment of canine lymphoma. Verdinexor is a selective inhibitor of nuclear export (SINE) compound, and this family of drug has demonstrated encouraging results in preclinical studies when combined with other chemotherapeutic drugs.
Study Details -
Long-Acting Analgesic for the Control of Elbow Pain in Dogs
OpenThis is an exploratory study to evaluate the safety and effectiveness of concomitant intraarticular (IA) and peri-neural (PN) injections of an investigational veterinary product for the control of elbow pain in dogs. This 28-day study also includes a long term follow up at 3 and 6 months.
Study Details -
Metabolomics Trial to Evaluate for Systemic Consequences of Intestinal Dysbiosis
ClosedThe intestinal microbiota are highly functional, with a combined genome (termed the microbiome) that is approximately 130-160 times larger than the human or canine genome. The microbiome is a highly functional organ and produces approximately 1,000 different metabolites, many of which have systemic effects in the dog.
Study Details -
ORBITS Clinical Study
OpenDespite years of active research in the field, high mortality rates associated with sepsis have remained unchanged over the last three decades; we aim to change this!
Study Details -
Pneumonia Pathogen Analysis
OpenPneumonia (infection in the lungs) is a common diagnosis in dogs and cats and can be caused by a variety of pathogens (i.e., bacteria, viruses, fungal organisms). Collecting fluid samples from the lungs of patients with pneumonia allows for tests to be performed that can identify the organism causing the infection.
Study Details -
Safety and Effectiveness of Long-Acting Intra-Articular and Peri-Neural Injections for the Management of Elbow Pain in Dogs
OpenThis is an exploratory study to evaluate the safety and effectiveness of concomitant intraarticular (IA) and peri-neural (PN) injections of an investigational veterinary product for the control of elbow pain in dogs. This 28-day study also includes a long term follow up at 3 and 6 months.
Study Details -
Minimally Invasive Metastasectomy in Canines (MIMIC)
OpenFollowing removal of the primary tumor and adjuvant chemotherapy, the development of lung metastasis is the most common cause of mortality in dogs with osteosarcoma. A distinctive feature of lung metastases of osteosarcoma in human patients is the surprising benefit that can result from surgical resection of the lung nodules. The use of surgery to
Study Details -
Atopic Dermatitis Clinical Trial
ClosedWheat Ridge Animal Hospital is participating in a clinical trial for a potential new, once-daily medicine for the treatment of atopic dermatitis in dogs. We are no longer enrolling dogs that meet eligibility requirements, including some restrictions on recent medications and therapies. Dogs, at least 12 months of age, diagnosed with atopic dermatitis may be
Study Details